Single Intravenous Dose Dalbavancin Pathway for the Treatment of Acute Bacterial Skin and Skin Structure Infections: Considerations for Emergency Department Implementation and Cost Savings Categories: pharmacology Posted on June 2, 2024
Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis Categories: high-impact pharmacology Posted on May 20, 2024
Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes Categories: pharmacology Posted on May 19, 2024
Serious Bleeding in Patients With Atrial Fibrillation Using Diltiazem With Apixaban or Rivaroxaban Categories: high-impact pharmacology Posted on April 15, 2024
Empagliflozin after Acute Myocardial Infarction Categories: high-impact pharmacology Posted on April 8, 2024
Efficacy and safety of sitagliptin with basal-plus insulin regimen versus insulin alone in non-critically ill hospitalized patients with type 2 diabetes: SITA-PLUS hospital trial Categories: pharmacology Posted on April 6, 2024
Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure Categories: high-impact pharmacology Posted on April 3, 2024
Clinical Efficacy of Beta-1 Selective Beta-Blockers Versus Propranolol in Patients With Thyroid Storm: A Retrospective Cohort Study Categories: pharmacology Posted on March 29, 2024
Efficacy of Angiotensin Receptor-Neprilysin Inhibitor and Its Renal Outcome in Heart Failure Patients: A Systematic Review of Randomized Clinical Trials Categories: pharmacology Posted on March 22, 2024
Effect of Dobutamine on Patients with Septic Shock: A Retrospective Nationwide Study Categories: pharmacology Posted on March 20, 2024
Melatonin does not reduce delirium severity in hospitalized older adults: Results of a randomized placebo-controlled trial Categories: pharmacology research Posted on March 4, 2024
Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study Categories: pharmacology Posted on March 1, 2024
Nephrotoxic Risk Associated With Combination Therapy of Vancomycin and Piperacillin-Tazobactam in Critically Ill Patients With Chronic Kidney Disease Categories: pharmacology Posted on February 28, 2024
Effectiveness and safety of early treatment with spironolactone for new-onset acute heart failure Categories: high-impact pharmacology Posted on February 28, 2024
Efficacy of L-ornithine L-aspartate for minimal hepatic encephalopathy in patients with cirrhosis: A meta-analysis of randomized controlled trials Categories: meta-analysis pharmacology research Posted on February 25, 2024
Optimizing warfarin dosing for patients with atrial fibrillation using machine learning Categories: pharmacology Posted on February 24, 2024
Effectiveness, Safety, and Costs of Thromboprophylaxis with Enoxaparin or Unfractionated Heparin Among Medical Inpatients With Chronic Obstructive Pulmonary Disease or Heart Failure Categories: pharmacology Posted on February 23, 2024
Efficacy and safety of dorzagliatin, a novel glucokinase activators, in the treatment of T2DM: A meta-analysis of randomized controlled trials Categories: meta-analysis pharmacology research Posted on February 23, 2024
Vonoprazan: A Review in Helicobacter pylori Infection Categories: pharmacology review Posted on February 22, 2024
Things We Do for No Reason™: Furosemide-albumin coadministration for diuretic resistance Categories: high-impact pharmacology Posted on February 19, 2024
Cefepime-Taniborbactam in Complicated Urinary Tract Infection Categories: pharmacology Posted on February 14, 2024
Association of SGLT2 inhibitor dapagliflozin with risks of acute kidney injury and all-cause mortality in acute myocardial infarction patients Categories: pharmacology Posted on February 6, 2024
Things We Do for No ReasonTM : Dose adjusting apixaban in acute kidney injury Categories: high-impact pharmacology Posted on January 31, 2024
Randomized Trial of Macitentan/Tadalafil Single-Tablet Combination Therapy for Pulmonary Arterial Hypertension Categories: high-impact pharmacology research Posted on January 24, 2024
Impact of Limiting Vancomycin Loading Doses in Patients With Methicillin-resistant Staphylococcus aureus Infections After Hospital Protocol Revision Categories: pharmacology Posted on January 15, 2024
Effects of sodium-glucose co-transporter 2 inhibitors on heart failure events in chronic kidney disease: a systematic review and meta-analysis Categories: pharmacology Posted on January 13, 2024
Sodium-glucose Cotransporter-2 Inhibitors Stabilize Coronary Plaques in Acute Coronary Syndrome with Diabetes Mellitus Categories: pharmacology Posted on January 12, 2024
Once-weekly Insulin Icodec Versus Once-daily Long-acting Insulin for Type II Diabetes: A Meta-analysis of Randomized Controlled Trials Categories: pharmacology Posted on January 12, 2024
Efficacy and safety of macrolide therapy for adult asthma: A systematic review and meta-analysis Categories: pharmacology Posted on January 11, 2024
The impact of early in-hospital use of PCSK9 inhibitors on cardiovascular outcomes in acute coronary syndrome patients: A systematic review and meta-analysis Categories: meta-analysis pharmacology Posted on January 11, 2024
Oral linezolid compared with benzathine penicillin G for treatment of early syphilis in adults (Trep-AB Study) in Spain: a prospective, open-label, non-inferiority, randomised controlled trial Categories: pharmacology Posted on January 11, 2024
Efficacy and safety of once-weekly basal insulin versus once-daily basal insulin in patients with type 2 diabetes: A systematic review and meta-analysis Categories: pharmacology Posted on January 11, 2024
Beta-blocker therapy in heart failure with preserved ejection fraction (B-HFpEF): a systematic review and meta-analysis Categories: pharmacology Posted on January 6, 2024
Chapter 3: Clinical Trials of Sodium-Glucose Co-Transporter-2 Inhibitors for Treatment of Heart Failure Categories: pharmacology Posted on January 6, 2024
Comparative cardiovascular benefits of individual SGLT2 inhibitors in type 2 diabetes and heart failure: a systematic review and network meta-analysis of randomized controlled trials Categories: pharmacology Posted on January 5, 2024
A comparison of clinical outcomes associated with dosing metronidazole every 8?hours versus every 12?hours: a systematic review and metaanalysis Categories: pharmacology Posted on January 4, 2024
Rates of diabetic ketoacidosis with empagliflozin use during hospitalization for acute heart failure Categories: pharmacology Posted on January 3, 2024
Safety and Efficacy of Reduced-Dose Versus Full-Dose Alteplase for Acute Pulmonary Embolism: A Multicenter Observational Comparative Effectiveness Study Categories: pharmacology Posted on January 2, 2024
Dual Antiplatelet Treatment up to 72 Hours after Ischemic Stroke Categories: pharmacology Posted on December 29, 2023
Association of vancomycin-induced acute kidney injury with trough versus AUC monitoring in patients receiving extended durations of therapy Categories: pharmacology Posted on December 29, 2023
SGLT2 Inhibitors for Heart Failure with Preserved Ejection Fraction: What Hospitalists Need to Know Categories: pharmacology Posted on December 29, 2023
Fixed-Dose Phenobarbital Versus As-Needed Benzodiazepines for the Management of Alcohol Withdrawal in Acute Care General Internal Medicine Categories: pharmacology Posted on December 27, 2023
Norepinephrine versus epinephrine for hemodynamic support in post-cardiac arrest shock: A systematic review Categories: pharmacology Posted on December 27, 2023
Efficacy and Safety of Apixaban Compared to Warfarin for Nonvalvular Atrial Fibrillation in End-Stage Renal Disease on Hemodialysis Categories: pharmacology Posted on December 27, 2023
Vericiguat treatment of heart failure: A systematic review and meta-analysis Categories: pharmacology Posted on December 22, 2023
The Impact of Midodrine On Guideline-Directed Medical Therapy in Patients Admitted with Systolic Heart Failure Categories: pharmacology Posted on December 21, 2023
Clinical effect of high-flow nasal cannula oxygen therapy combined with naloxone on severe respiratory failure in older adult patients: a randomized controlled trial Categories: pharmacology Posted on December 11, 2023
Antistaphylococcal Efficacy of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients with Polymicrobial Infection with MSSA Bacteremia or Pneumonia Categories: pharmacology Posted on December 11, 2023
Intravenous albumin utilization audit at a large community hospital Categories: pharmacology Posted on December 11, 2023
Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study Categories: pharmacology Posted on December 10, 2023
Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease Categories: pharmacology Posted on December 6, 2023
Atorvastatin for patients with cirrhosis. A randomized, placebo-controlled trial Categories: pharmacology Posted on December 5, 2023
Patient Perspectives on Pharmacotherapy of Alcohol Dependence Categories: pharmacology Posted on December 5, 2023
Corticosteroids for preventing postherpetic neuralgia Categories: pharmacology Posted on December 5, 2023
High-dose versus low-dose intravenous nitroglycerine for sympathetic crashing acute pulmonary edema: a randomised controlled trial Categories: pharmacology Posted on December 5, 2023
Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists Categories: pharmacology Posted on November 30, 2023
The effect of sodium-glucose cotransporter 2 inhibitors in patients with chronic kidney disease with or without type 2 diabetes mellitus on cardiovascular and renal outcomes: A systematic review and meta-analysis Categories: pharmacology Posted on November 29, 2023
Sodium-glucose cotransporter 2 inhibitors are associated with reduced risk of mortality and readmissions in heart failure Categories: pharmacology Posted on November 27, 2023
The Role of SGLT2 Inhibitors on Heart Failure Outcomes in Nondiabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Categories: pharmacology Posted on November 21, 2023
Sodium glucose co-transporter 2 inhibitors and quality of life in patients with heart failure: a comprehensive systematic review and meta-analysis of randomized controlled trials Categories: pharmacology Posted on November 21, 2023
Clinical value of glucocorticoids for severe community-acquired pneumonia: A systematic review and meta-analysis based on randomized controlled trials Categories: pharmacology Posted on November 21, 2023
Utilization of cefepime therapeutic drug monitoring in febrile neutropenia patients with hematologic malignancies Categories: pharmacology Posted on November 20, 2023
Establishing the Safety of Phenobarbital Treatment of Alcohol Withdrawal Syndrome on General Medical Wards: A Retrospective Cohort Study Categories: pharmacology Posted on November 18, 2023
Renal safety and survival among acutely ill hospitalized patients treated by blockers of the Renin-Angiotensin axis or loop diuretics: a single-center retrospective analysis Categories: pharmacology Posted on November 17, 2023
Comparative Effect of Loop Diuretic Prescription on Mortality and Heart Failure Readmission Categories: pharmacology Posted on November 16, 2023
Torsemide vs Furosemide Among Patients With New-Onset vs Worsening Chronic Heart Failure: A Substudy of the TRANSFORM-HF Randomized Clinical Trial Categories: pharmacology Posted on November 13, 2023
SGLT2 Inhibitors to Slow Chronic Kidney Disease Progression: A Review Categories: pharmacology review Posted on November 11, 2023
Evaluation of Inpatient Sodium-Glucose Co-Transporter-2 Inhibitor Use in Patients Hospitalized for Acute Heart Failure Categories: pharmacology Posted on November 9, 2023
Oritavancin vs Standard of Care for Treatment of Nonendovascular Gram-Positive Bloodstream Infections Categories: pharmacology Posted on November 8, 2023
Changes in Oral Corticosteroid Utilization in Patients with COPD Following Initiation of FF/UMEC/VI Categories: pharmacology Posted on November 7, 2023
Evaluation of the Safety and Efficacy of Metformin Use in Hospitalized, Non-Critically Ill Patients Categories: pharmacology Posted on November 6, 2023
Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients with Atrial Fibrillation in the United States Categories: pharmacology Posted on November 6, 2023
Phenobarbital Treatment of Alcohol Withdrawal in the Emergency Department: A Systematic Review and Meta-analysis Categories: pharmacology Posted on November 3, 2023
Thalidomide for Recurrent Bleeding Due to Small-Intestinal Angiodysplasia Categories: pharmacology Posted on November 1, 2023
Ceftriaxone and the Risk of Ventricular Arrhythmia, Cardiac Arrest, and Death Among Patients Receiving Lansoprazole Categories: pharmacology Posted on October 26, 2023
Naloxegol versus Methylnaltrexone for Opioid-Induced Constipation in Critically Ill Patients Categories: pharmacology Posted on October 26, 2023
Ertapenem Versus Meropenem for the Treatment of Extended Spectrum Beta-Lactamase-Producing Enterobacterales Bacteremia in Critically Ill Patients Categories: pharmacology Posted on October 26, 2023
Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials Categories: pharmacology Posted on October 25, 2023
Safety and Efficacy of Direct Oral Anticoagulant in Addition to Antiplatelet Therapy After Acute Coronary Syndrome: A Systemic Review and Meta-analysis of 53,869 Patients Categories: meta-analysis pharmacology Posted on October 25, 2023
Hospital-based opioid treatment: Expanding and sustaining the model in Texas Categories: pharmacology Posted on October 25, 2023
Landiolol and Organ Failure in Patients With Septic Shock: The STRESS-L Randomized Clinical Trial Categories: pharmacology Posted on October 25, 2023
Anticoagulation in atrial fibrillation. A large real-world update Categories: pharmacology Posted on October 25, 2023
Efficacy and Safety of Corticosteroid Therapy for Community-Acquired Pneumonia: A Meta-Analysis and Meta-Regression of Randomized, Controlled Trials Categories: meta-analysis pharmacology research Posted on October 25, 2023
Early Initiation of PCSK9 Inhibitor Therapy versus Placebo in Patients with Acute Coronary Syndrome: A Systematic Review and Meta-Analysis Categories: pharmacology Posted on October 24, 2023
Clinical Outcomes of Rifampicin Combination Therapy in Implant-Associated Infections due to Staphylococci and Streptococci: A Systematic Review and Meta-analyses Categories: pharmacology Posted on October 24, 2023
Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: an Individual Patient Data Meta-analysis of TWILIGHT and TICO Randomized Trials Categories: pharmacology Posted on October 23, 2023
Novel Nebulized Milrinone Formulation for the Treatment of Acute Heart Failure Requiring Inotropic Therapy: A Phase 1 Study Categories: pharmacology Posted on October 23, 2023
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction: A Meta-Analysis of Randomized Controlled Trials Categories: pharmacology Posted on October 23, 2023
Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trial Categories: pharmacology Posted on October 20, 2023
Intravenous high-dose vitamin C monotherapy for sepsis and septic shock: A meta-analysis of randomized controlled trials Categories: pharmacology Posted on October 20, 2023
Anticoagulation Bridging in Patients With Left Ventricular Assist Device: A Regional Analysis of HeartMate 3 Recipients Categories: pharmacology Posted on October 20, 2023
Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial Categories: pharmacology Posted on October 20, 2023
A Randomized, Controlled Trial of Prulifloxacin as Conversion Therapy after Intravenous Carbapenem in the Treatment of Acute Pyelonephritis Caused by Third Generation Cephalosporin Resistant Pathogens: A Pilot Study Categories: pharmacology Posted on October 19, 2023
Acute heart failure: current pharmacological treatment and perspectives Categories: pharmacology Posted on October 18, 2023
Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial Categories: pharmacology Posted on October 18, 2023October 30, 2023
Impact of Guideline-Directed Statin Intervention for Primary Prevention in Patients With Diabetes Categories: pharmacology Posted on October 18, 2023
Multiple Myeloma and the Role of Bisphosphonates in Its Management Categories: pharmacology Posted on October 17, 2023
Effectiveness and safety of non-vitamin K oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke: A systematic review and meta-analysis Categories: pharmacology Posted on October 17, 2023
? blockers switched to first-line therapy in hypertension Categories: pharmacology Posted on October 16, 2023